During the past decade, Diabetes and Endocrine Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes and Endocrine Associates" #1 collaborator was "Jaeb Center for Health Research" with 1 trials as a collaborator, "Medstar Health Research Institute" with 1 trials as a collaborator and "Valeritas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes and Endocrine Associates" are "Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Diabetes" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Gastroparesis" (1 trials). Many other conditions were trialed in "Diabetes and Endocrine Associates" in a lesser frequency.

Most popular intervention types in "Diabetes and Endocrine Associates" are "Device" (5 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "12.7mm x 29G Pen Needle" (1 trials), "4 mm x 32G Pen Needle" (1 trials), "8mm x 31G Pen Needle" (1 trials), "CGM" (1 trials) and "Continuous Glucose Monitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes and Endocrine Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes and Endocrine Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Diabetes and Endocrine Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes and Endocrine Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".